Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-01 @ 10:45 PM
Study NCT ID:
NCT02181127
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2013-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Closed-Loop Glucagon Administration For Hypoglycemia Treatment
Sponsor:
Massachusetts General Hospital
Organization:
Study Overview
Official Title:
Closed-Loop Glucagon Administration for the Automated Prevention and Treatment of Hypoglycemia
Status:
COMPLETED
Status Verified Date:
2018-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will test the hypothesis that a wearable automated bionic pancreas system that automatically delivers glucagon only can prevent or treat hypoglycemia vs. usual care for people with type 1 diabetes \> 21 years old.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: